SPRINGWORKS THERAPEUTICS, INC. — Revenue by Fiscal Year
6 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/4f60e92e-8b13-4348-b292-8176c2d05073/serie/revenue
| Fiscal year | Revenue | Period | Evidence |
|---|---|---|---|
| FY 2024 | $172.0M | 2024-01-01 – 2024-12-31 | evidence 0001773427-25-000010 |
| FY 2023 | $5.4M | 2023-01-01 – 2023-12-31 | evidence 0001773427-24-000010 |
| FY 2022 | $0 | 2022-01-01 – 2022-12-31 | evidence 0001773427-23-000010 |
| FY 2021 | $0 | 2021-01-01 – 2021-12-31 | evidence 0001773427-22-000011 |
| FY 2020 | $35.0M | 2020-01-01 – 2020-12-31 | evidence 0001558370-21-001708 |
| FY 2019 | $0 | 2019-01-01 – 2019-12-31 | evidence 0001773427-22-000011 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
SPRINGWORKS THERAPEUTICS, INC. — all facts · Net Income · Operating Income